

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 7.06371499 |
| 2 | B cell receptor signaling pathway (GO:0050853) | 6.04643157 |
| 3 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.99634520 |
| 4 | immunoglobulin mediated immune response (GO:0016064) | 5.83009321 |
| 5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.50809761 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.46365768 |
| 7 | regulation of antigen processing and presentation (GO:0002577) | 5.43782146 |
| 8 | defense response to protozoan (GO:0042832) | 5.08663962 |
| 9 | negative regulation of cell killing (GO:0031342) | 4.90117779 |
| 10 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.90117779 |
| 11 | neutrophil activation involved in immune response (GO:0002283) | 4.89654157 |
| 12 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.86400646 |
| 13 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.78456121 |
| 14 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.73302351 |
| 15 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.70244372 |
| 16 | positive thymic T cell selection (GO:0045059) | 4.68640155 |
| 17 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.62190721 |
| 18 | regulation of B cell differentiation (GO:0045577) | 4.57071748 |
| 19 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.50924915 |
| 20 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.50924915 |
| 21 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.50924915 |
| 22 | modulation by symbiont of host immune response (GO:0052553) | 4.50924915 |
| 23 | positive regulation by symbiont of host defense response (GO:0052509) | 4.50924915 |
| 24 | modulation by symbiont of host defense response (GO:0052031) | 4.50924915 |
| 25 | B cell mediated immunity (GO:0019724) | 4.47705543 |
| 26 | positive regulation of B cell differentiation (GO:0045579) | 4.38303420 |
| 27 | response to protozoan (GO:0001562) | 4.38035389 |
| 28 | macrophage activation involved in immune response (GO:0002281) | 4.36916755 |
| 29 | interferon-gamma-mediated signaling pathway (GO:0060333) | 4.27505148 |
| 30 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.27134783 |
| 31 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.19550676 |
| 32 | positive regulation of antigen processing and presentation (GO:0002579) | 4.15992262 |
| 33 | regulation of gamma-delta T cell activation (GO:0046643) | 4.01328462 |
| 34 | detection of bacterium (GO:0016045) | 4.00133144 |
| 35 | positive regulation of type 2 immune response (GO:0002830) | 3.99335278 |
| 36 | type I interferon signaling pathway (GO:0060337) | 3.91361768 |
| 37 | cellular response to type I interferon (GO:0071357) | 3.91361768 |
| 38 | negative thymic T cell selection (GO:0045060) | 3.90320441 |
| 39 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.88972442 |
| 40 | regulation of germinal center formation (GO:0002634) | 3.88431339 |
| 41 | response to type I interferon (GO:0034340) | 3.87565508 |
| 42 | detection of other organism (GO:0098543) | 3.86966779 |
| 43 | respiratory burst (GO:0045730) | 3.85236205 |
| 44 | negative T cell selection (GO:0043383) | 3.79590399 |
| 45 | positive T cell selection (GO:0043368) | 3.76211437 |
| 46 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.74127735 |
| 47 | T cell selection (GO:0045058) | 3.72481366 |
| 48 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.70723505 |
| 49 | thymic T cell selection (GO:0045061) | 3.70378175 |
| 50 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.63260257 |
| 51 | regulation of mast cell degranulation (GO:0043304) | 3.63146258 |
| 52 | neutrophil activation (GO:0042119) | 3.62746373 |
| 53 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.61777804 |
| 54 | positive regulation of interferon-alpha production (GO:0032727) | 3.56041309 |
| 55 | T cell costimulation (GO:0031295) | 3.55638828 |
| 56 | positive regulation of mast cell activation (GO:0033005) | 3.50693656 |
| 57 | lymphocyte costimulation (GO:0031294) | 3.50392477 |
| 58 | myeloid cell activation involved in immune response (GO:0002275) | 3.47831976 |
| 59 | regulation of interferon-alpha production (GO:0032647) | 3.46683961 |
| 60 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.43848577 |
| 61 | positive regulation of mast cell degranulation (GO:0043306) | 3.43848577 |
| 62 | positive regulation of B cell proliferation (GO:0030890) | 3.42767946 |
| 63 | response to peptidoglycan (GO:0032494) | 3.38099242 |
| 64 | B cell homeostasis (GO:0001782) | 3.36278725 |
| 65 | granulocyte activation (GO:0036230) | 3.35412400 |
| 66 | positive regulation of B cell activation (GO:0050871) | 3.35362289 |
| 67 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.34470347 |
| 68 | regulation of mast cell activation (GO:0033003) | 3.34458373 |
| 69 | leukocyte aggregation (GO:0070486) | 3.34056000 |
| 70 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.32539150 |
| 71 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.29509281 |
| 72 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.28400318 |
| 73 | regulation of B cell proliferation (GO:0030888) | 3.24681245 |
| 74 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.23081782 |
| 75 | regulation of type 2 immune response (GO:0002828) | 3.22811809 |
| 76 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.22238321 |
| 77 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.22238321 |
| 78 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.22215098 |
| 79 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.21755388 |
| 80 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.19877883 |
| 81 | negative regulation of alpha-beta T cell activation (GO:0046636) | 3.17550858 |
| 82 | B cell proliferation (GO:0042100) | 3.10635787 |
| 83 | cellular response to interferon-gamma (GO:0071346) | 3.10321251 |
| 84 | microglial cell activation (GO:0001774) | 3.09390315 |
| 85 | cellular response to interleukin-15 (GO:0071350) | 3.07236428 |
| 86 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.07191506 |
| 87 | positive regulation of interferon-gamma production (GO:0032729) | 3.04897517 |
| 88 | response to host immune response (GO:0052572) | 3.04024605 |
| 89 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.04024605 |
| 90 | detection of external biotic stimulus (GO:0098581) | 3.03450344 |
| 91 | positive regulation of granulocyte differentiation (GO:0030854) | 3.01823192 |
| 92 | positive regulation of humoral immune response (GO:0002922) | 3.00988998 |
| 93 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.00328937 |
| 94 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.99353159 |
| 95 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.99326502 |
| 96 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.98756565 |
| 97 | T cell migration (GO:0072678) | 2.96964679 |
| 98 | regulation of B cell activation (GO:0050864) | 2.92023339 |
| 99 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.89995980 |
| 100 | response to interleukin-15 (GO:0070672) | 2.89442995 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.44719870 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.77593125 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.07065318 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.87454076 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.61684034 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.53051589 |
| 7 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.52094711 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.31728566 |
| 9 | MYC_22102868_ChIP-Seq_BL_Human | 3.30651619 |
| 10 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 3.24259346 |
| 11 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.09467924 |
| 12 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.95057660 |
| 13 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.88483095 |
| 14 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.71511511 |
| 15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.70757869 |
| 16 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.64450963 |
| 17 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.60892020 |
| 18 | MYB_26560356_Chip-Seq_TH2_Human | 2.57872217 |
| 19 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.57523305 |
| 20 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.54912853 |
| 21 | MAF_26560356_Chip-Seq_TH1_Human | 2.36730818 |
| 22 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.31743652 |
| 23 | SPI1_23127762_ChIP-Seq_K562_Human | 2.31701527 |
| 24 | UTX_26944678_Chip-Seq_JUKART_Human | 2.24050021 |
| 25 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.20860276 |
| 26 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.20716656 |
| 27 | MYB_26560356_Chip-Seq_TH1_Human | 2.18686444 |
| 28 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.13668013 |
| 29 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.13613692 |
| 30 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.09755994 |
| 31 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.01838500 |
| 32 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.00333367 |
| 33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.99901457 |
| 34 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.97202656 |
| 35 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.94264710 |
| 36 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.81038888 |
| 37 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.80386897 |
| 38 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.79251119 |
| 39 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.77634470 |
| 40 | MAF_26560356_Chip-Seq_TH2_Human | 1.76307698 |
| 41 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.71946497 |
| 42 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.68125343 |
| 43 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67606564 |
| 44 | GATA1_22025678_ChIP-Seq_K562_Human | 1.65351929 |
| 45 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.65178569 |
| 46 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.58904809 |
| 47 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.58213016 |
| 48 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.51526456 |
| 49 | GATA3_26560356_Chip-Seq_TH2_Human | 1.49371550 |
| 50 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.47534501 |
| 51 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.44117519 |
| 52 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.42674631 |
| 53 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.41933574 |
| 54 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.38383698 |
| 55 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.34649447 |
| 56 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.31963659 |
| 57 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.28297195 |
| 58 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.26438071 |
| 59 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.24796630 |
| 60 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.24751882 |
| 61 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23735606 |
| 62 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23338835 |
| 63 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.22858524 |
| 64 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.20762147 |
| 65 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.18624318 |
| 66 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.17973914 |
| 67 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.17345183 |
| 68 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.17270699 |
| 69 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.14676116 |
| 70 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.13450966 |
| 71 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12698809 |
| 72 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.11989770 |
| 73 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.11738382 |
| 74 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.10730901 |
| 75 | * P300_27268052_Chip-Seq_Bcells_Human | 1.10671756 |
| 76 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.06584049 |
| 77 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 1.05343643 |
| 78 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.05129308 |
| 79 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.04679090 |
| 80 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03782461 |
| 81 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02647287 |
| 82 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.01236337 |
| 83 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99786038 |
| 84 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99584789 |
| 85 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99258111 |
| 86 | GATA1_19941826_ChIP-Seq_K562_Human | 0.98004750 |
| 87 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.97726138 |
| 88 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96990156 |
| 89 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96966461 |
| 90 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94653350 |
| 91 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.93379568 |
| 92 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91328407 |
| 93 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.91060318 |
| 94 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.90693255 |
| 95 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.87910034 |
| 96 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.85407402 |
| 97 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83611428 |
| 98 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.82025302 |
| 99 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.81407816 |
| 100 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.77818036 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.98254677 |
| 2 | MP0001800_abnormal_humoral_immune | 3.92980484 |
| 3 | MP0005387_immune_system_phenotype | 3.86153078 |
| 4 | MP0001790_abnormal_immune_system | 3.86153078 |
| 5 | MP0005671_abnormal_response_to | 3.76286434 |
| 6 | MP0003303_peritoneal_inflammation | 3.64937756 |
| 7 | MP0002452_abnormal_antigen_presenting | 3.19954025 |
| 8 | MP0000685_abnormal_immune_system | 3.18713225 |
| 9 | MP0002723_abnormal_immune_serum | 3.14146315 |
| 10 | MP0005000_abnormal_immune_tolerance | 3.12251741 |
| 11 | MP0003724_increased_susceptibility_to | 3.10221697 |
| 12 | MP0003436_decreased_susceptibility_to | 3.09804035 |
| 13 | MP0002420_abnormal_adaptive_immunity | 2.98317687 |
| 14 | MP0001819_abnormal_immune_cell | 2.93001666 |
| 15 | MP0009785_altered_susceptibility_to | 2.89896699 |
| 16 | MP0005025_abnormal_response_to | 2.87184146 |
| 17 | MP0002419_abnormal_innate_immunity | 2.77067659 |
| 18 | MP0003763_abnormal_thymus_physiology | 2.73633077 |
| 19 | MP0002148_abnormal_hypersensitivity_rea | 2.61891493 |
| 20 | MP0002398_abnormal_bone_marrow | 2.39996427 |
| 21 | MP0000716_abnormal_immune_system | 2.30157373 |
| 22 | MP0006082_CNS_inflammation | 2.24385094 |
| 23 | MP0002405_respiratory_system_inflammati | 2.10362821 |
| 24 | MP0000689_abnormal_spleen_morphology | 2.08711321 |
| 25 | MP0005310_abnormal_salivary_gland | 1.95849050 |
| 26 | MP0003172_abnormal_lysosome_physiology | 1.90894936 |
| 27 | MP0005464_abnormal_platelet_physiology | 1.87494075 |
| 28 | MP0003183_abnormal_peptide_metabolism | 1.82099742 |
| 29 | MP0005075_abnormal_melanosome_morpholog | 1.81920130 |
| 30 | MP0002429_abnormal_blood_cell | 1.81377731 |
| 31 | MP0002722_abnormal_immune_system | 1.78470834 |
| 32 | MP0003191_abnormal_cellular_cholesterol | 1.78145788 |
| 33 | MP0010155_abnormal_intestine_physiology | 1.74921406 |
| 34 | MP0001845_abnormal_inflammatory_respons | 1.67738712 |
| 35 | MP0003300_gastrointestinal_ulcer | 1.65849136 |
| 36 | MP0004381_abnormal_hair_follicle | 1.53605543 |
| 37 | MP0001873_stomach_inflammation | 1.51525912 |
| 38 | MP0005058_abnormal_lysosome_morphology | 1.46523444 |
| 39 | MP0002138_abnormal_hepatobiliary_system | 1.45158106 |
| 40 | MP0000703_abnormal_thymus_morphology | 1.43766949 |
| 41 | MP0008469_abnormal_protein_level | 1.41991551 |
| 42 | MP0000465_gastrointestinal_hemorrhage | 1.41125096 |
| 43 | MP0001533_abnormal_skeleton_physiology | 1.39056782 |
| 44 | MP0009333_abnormal_splenocyte_physiolog | 1.38051801 |
| 45 | MP0003866_abnormal_defecation | 1.33113088 |
| 46 | MP0009278_abnormal_bone_marrow | 1.31479672 |
| 47 | MP0001853_heart_inflammation | 1.31389642 |
| 48 | MP0009764_decreased_sensitivity_to | 1.28537318 |
| 49 | MP0004947_skin_inflammation | 1.21576575 |
| 50 | MP0003787_abnormal_imprinting | 1.16809747 |
| 51 | MP0001348_abnormal_lacrimal_gland | 1.13438730 |
| 52 | MP0008004_abnormal_stomach_pH | 1.11717699 |
| 53 | MP0003075_altered_response_to | 1.11655662 |
| 54 | MP0005166_decreased_susceptibility_to | 1.01677320 |
| 55 | MP0002166_altered_tumor_susceptibility | 1.00603937 |
| 56 | MP0001545_abnormal_hematopoietic_system | 0.98243503 |
| 57 | MP0005397_hematopoietic_system_phenotyp | 0.98243503 |
| 58 | MP0002933_joint_inflammation | 0.97464038 |
| 59 | MP0004883_abnormal_blood_vessel | 0.94404665 |
| 60 | MP0002396_abnormal_hematopoietic_system | 0.93028668 |
| 61 | MP0005645_abnormal_hypothalamus_physiol | 0.92207389 |
| 62 | MP0003690_abnormal_glial_cell | 0.92206793 |
| 63 | MP0004510_myositis | 0.90412008 |
| 64 | MP0000858_altered_metastatic_potential | 0.90337443 |
| 65 | MP0002132_abnormal_respiratory_system | 0.86954220 |
| 66 | MP0001851_eye_inflammation | 0.85604658 |
| 67 | MP0005451_abnormal_body_composition | 0.84781810 |
| 68 | MP0002928_abnormal_bile_duct | 0.83723475 |
| 69 | MP0001663_abnormal_digestive_system | 0.81848192 |
| 70 | MP0000015_abnormal_ear_pigmentation | 0.80611783 |
| 71 | MP0000490_abnormal_crypts_of | 0.80221589 |
| 72 | MP0002009_preneoplasia | 0.77015656 |
| 73 | MP0002653_abnormal_ependyma_morphology | 0.76218938 |
| 74 | MP0009840_abnormal_foam_cell | 0.72941922 |
| 75 | MP0002998_abnormal_bone_remodeling | 0.70813686 |
| 76 | MP0000343_altered_response_to | 0.69634528 |
| 77 | MP0000249_abnormal_blood_vessel | 0.68432530 |
| 78 | MP0002006_tumorigenesis | 0.63820690 |
| 79 | MP0002019_abnormal_tumor_incidence | 0.62137807 |
| 80 | MP0008874_decreased_physiological_sensi | 0.61533333 |
| 81 | MP0002693_abnormal_pancreas_physiology | 0.60118620 |
| 82 | MP0003045_fibrosis | 0.59660984 |
| 83 | MP0003656_abnormal_erythrocyte_physiolo | 0.59407199 |
| 84 | MP0009763_increased_sensitivity_to | 0.59274325 |
| 85 | MP0008961_abnormal_basal_metabolism | 0.58513466 |
| 86 | MP0003252_abnormal_bile_duct | 0.57677214 |
| 87 | MP0008877_abnormal_DNA_methylation | 0.57672582 |
| 88 | MP0005174_abnormal_tail_pigmentation | 0.57554625 |
| 89 | MP0004142_abnormal_muscle_tone | 0.54291560 |
| 90 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.51925956 |
| 91 | MP0003828_pulmonary_edema | 0.51389989 |
| 92 | MP0002277_abnormal_respiratory_mucosa | 0.50930005 |
| 93 | MP0005535_abnormal_body_temperature | 0.49705880 |
| 94 | MP0001986_abnormal_taste_sensitivity | 0.49580752 |
| 95 | MP0002163_abnormal_gland_morphology | 0.49273968 |
| 96 | MP0005381_digestive/alimentary_phenotyp | 0.46212789 |
| 97 | MP0005390_skeleton_phenotype | 0.45387415 |
| 98 | MP0005164_abnormal_response_to | 0.42981660 |
| 99 | MP0003091_abnormal_cell_migration | 0.42848185 |
| 100 | MP0006036_abnormal_mitochondrial_physio | 0.42489058 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Agammaglobulinemia (HP:0004432) | 7.87217945 |
| 2 | Eczematoid dermatitis (HP:0000976) | 5.88571239 |
| 3 | Meningitis (HP:0001287) | 5.60683197 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 5.59713828 |
| 5 | Cellulitis (HP:0100658) | 5.22533335 |
| 6 | Recurrent abscess formation (HP:0002722) | 5.11853426 |
| 7 | Mediastinal lymphadenopathy (HP:0100721) | 4.90300505 |
| 8 | Abnormality of macrophages (HP:0004311) | 4.84401675 |
| 9 | Recurrent fungal infections (HP:0002841) | 4.65262959 |
| 10 | Chronic obstructive pulmonary disease (HP:0006510) | 4.63317830 |
| 11 | Obstructive lung disease (HP:0006536) | 4.63317830 |
| 12 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.51261418 |
| 13 | Recurrent bronchitis (HP:0002837) | 4.37461143 |
| 14 | Papilloma (HP:0012740) | 4.20376267 |
| 15 | Verrucae (HP:0200043) | 4.20376267 |
| 16 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.11633554 |
| 17 | Recurrent cutaneous fungal infections (HP:0011370) | 4.11633554 |
| 18 | Recurrent pneumonia (HP:0006532) | 4.03498452 |
| 19 | Panhypogammaglobulinemia (HP:0003139) | 4.01901882 |
| 20 | Recurrent skin infections (HP:0001581) | 4.01192979 |
| 21 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.97874917 |
| 22 | Colitis (HP:0002583) | 3.95868329 |
| 23 | Vasculitis (HP:0002633) | 3.91477436 |
| 24 | Inflammation of the large intestine (HP:0002037) | 3.87349412 |
| 25 | Gastrointestinal stroma tumor (HP:0100723) | 3.87136022 |
| 26 | Recurrent viral infections (HP:0004429) | 3.87041215 |
| 27 | Osteomyelitis (HP:0002754) | 3.78476002 |
| 28 | Gastrointestinal inflammation (HP:0004386) | 3.72848614 |
| 29 | Stomatitis (HP:0010280) | 3.64662354 |
| 30 | Myositis (HP:0100614) | 3.63873494 |
| 31 | Recurrent sinusitis (HP:0011108) | 3.58248260 |
| 32 | Sepsis (HP:0100806) | 3.57770955 |
| 33 | Increased IgE level (HP:0003212) | 3.52973245 |
| 34 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.52219185 |
| 35 | Encephalitis (HP:0002383) | 3.49329228 |
| 36 | Recurrent lower respiratory tract infections (HP:0002783) | 3.44683498 |
| 37 | Chronic sinusitis (HP:0011109) | 3.42712231 |
| 38 | Optic neuritis (HP:0100653) | 3.38616635 |
| 39 | Retrobulbar optic neuritis (HP:0100654) | 3.38616635 |
| 40 | Urticaria (HP:0001025) | 3.30750634 |
| 41 | Pulmonary infiltrates (HP:0002113) | 3.28668263 |
| 42 | Orchitis (HP:0100796) | 3.25159404 |
| 43 | Gastrointestinal infarctions (HP:0005244) | 3.24868708 |
| 44 | Lymphopenia (HP:0001888) | 3.19794385 |
| 45 | Skin rash (HP:0000988) | 3.06441152 |
| 46 | Prolonged bleeding time (HP:0003010) | 2.94104593 |
| 47 | Abnormality of the prostate (HP:0008775) | 2.90012349 |
| 48 | IgM deficiency (HP:0002850) | 2.87440239 |
| 49 | Abnormality of B cell number (HP:0010975) | 2.86839213 |
| 50 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.84927436 |
| 51 | Restrictive lung disease (HP:0002091) | 2.83981513 |
| 52 | Chest pain (HP:0100749) | 2.78574334 |
| 53 | B lymphocytopenia (HP:0010976) | 2.77838784 |
| 54 | Hemoptysis (HP:0002105) | 2.74083499 |
| 55 | Pulmonary fibrosis (HP:0002206) | 2.67006559 |
| 56 | IgG deficiency (HP:0004315) | 2.65217522 |
| 57 | Bronchitis (HP:0012387) | 2.63220944 |
| 58 | Abnormality of the pleura (HP:0002103) | 2.59256459 |
| 59 | Petechiae (HP:0000967) | 2.49330690 |
| 60 | Increased IgM level (HP:0003496) | 2.48695096 |
| 61 | Epistaxis (HP:0000421) | 2.48245542 |
| 62 | Gingivitis (HP:0000230) | 2.45861527 |
| 63 | Skin ulcer (HP:0200042) | 2.43097514 |
| 64 | Keratoconjunctivitis (HP:0001096) | 2.40721220 |
| 65 | Abnormality of T cells (HP:0002843) | 2.40457340 |
| 66 | Keratoconjunctivitis sicca (HP:0001097) | 2.40280704 |
| 67 | Hypertensive crisis (HP:0100735) | 2.39331884 |
| 68 | Chronic otitis media (HP:0000389) | 2.37793081 |
| 69 | T lymphocytopenia (HP:0005403) | 2.33080226 |
| 70 | Autoimmune thrombocytopenia (HP:0001973) | 2.28190765 |
| 71 | Abnormality of T cell physiology (HP:0011840) | 2.28094417 |
| 72 | Pulmonary embolism (HP:0002204) | 2.28022336 |
| 73 | Lymphoma (HP:0002665) | 2.27979246 |
| 74 | Viral hepatitis (HP:0006562) | 2.27675983 |
| 75 | Gangrene (HP:0100758) | 2.26995048 |
| 76 | Abnormality of T cell number (HP:0011839) | 2.26936211 |
| 77 | Spontaneous hematomas (HP:0007420) | 2.25262282 |
| 78 | Abnormality of the peritoneum (HP:0002585) | 2.24328404 |
| 79 | Granulocytopenia (HP:0001913) | 2.22271340 |
| 80 | Severe combined immunodeficiency (HP:0004430) | 2.22012279 |
| 81 | Leukocytosis (HP:0001974) | 2.17551045 |
| 82 | Pustule (HP:0200039) | 2.16464785 |
| 83 | Emphysema (HP:0002097) | 2.15435131 |
| 84 | Recurrent otitis media (HP:0000403) | 2.13183917 |
| 85 | Hypergammaglobulinemia (HP:0010702) | 2.11239394 |
| 86 | Eosinophilia (HP:0001880) | 2.05907244 |
| 87 | Xerostomia (HP:0000217) | 2.05411777 |
| 88 | Polyneuropathy (HP:0001271) | 2.01635045 |
| 89 | Episodic fever (HP:0001954) | 2.01504235 |
| 90 | Dysostosis multiplex (HP:0000943) | 2.00503965 |
| 91 | Gingival bleeding (HP:0000225) | 1.99636048 |
| 92 | Hematochezia (HP:0002573) | 1.98082490 |
| 93 | Arthralgia (HP:0002829) | 1.96311979 |
| 94 | Purpura (HP:0000979) | 1.93911385 |
| 95 | Autoimmune hemolytic anemia (HP:0001890) | 1.91849359 |
| 96 | Arterial thrombosis (HP:0004420) | 1.86809061 |
| 97 | Abnormality of eosinophils (HP:0001879) | 1.84823138 |
| 98 | Neutropenia (HP:0001875) | 1.82027246 |
| 99 | Albinism (HP:0001022) | 1.81069771 |
| 100 | Abnormality of male internal genitalia (HP:0000022) | 1.79829144 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.41617446 |
| 2 | RIPK4 | 4.85664125 |
| 3 | BLK | 3.82973285 |
| 4 | TXK | 3.23731381 |
| 5 | BMPR2 | 2.99507137 |
| 6 | IRAK4 | 2.98662794 |
| 7 | TYK2 | 2.80277672 |
| 8 | CSF1R | 2.46195373 |
| 9 | SYK | 2.28741097 |
| 10 | MAP3K11 | 2.27897027 |
| 11 | GRK6 | 2.15073875 |
| 12 | BTK | 2.03094601 |
| 13 | ERN1 | 1.98399722 |
| 14 | IKBKE | 1.84632629 |
| 15 | LYN | 1.82181496 |
| 16 | KIT | 1.69332407 |
| 17 | CSK | 1.69020784 |
| 18 | TBK1 | 1.68263810 |
| 19 | TNK2 | 1.62947880 |
| 20 | FES | 1.62348486 |
| 21 | SIK2 | 1.60346277 |
| 22 | SIK3 | 1.60260571 |
| 23 | IKBKB | 1.57472839 |
| 24 | PRPF4B | 1.56645715 |
| 25 | MAP2K3 | 1.50721457 |
| 26 | ZAP70 | 1.48228833 |
| 27 | TAOK3 | 1.45393809 |
| 28 | TESK2 | 1.40209919 |
| 29 | GRK7 | 1.37962303 |
| 30 | JAK3 | 1.33570356 |
| 31 | HCK | 1.32272075 |
| 32 | MAPK12 | 1.31014031 |
| 33 | LCK | 1.28541826 |
| 34 | MARK3 | 1.24819787 |
| 35 | JAK1 | 1.22471858 |
| 36 | MAP3K13 | 1.19997899 |
| 37 | MAP3K3 | 1.18851484 |
| 38 | MAP3K14 | 1.17532023 |
| 39 | TAOK1 | 1.02706935 |
| 40 | PRKCQ | 0.99373333 |
| 41 | ITK | 0.96823794 |
| 42 | STK10 | 0.95994143 |
| 43 | JAK2 | 0.95421773 |
| 44 | MAPK15 | 0.95379664 |
| 45 | MATK | 0.94561471 |
| 46 | FGR | 0.90546272 |
| 47 | TEC | 0.86470334 |
| 48 | MAP3K12 | 0.82061367 |
| 49 | MAP3K10 | 0.80753450 |
| 50 | TAOK2 | 0.80133993 |
| 51 | FYN | 0.78690750 |
| 52 | PDK1 | 0.78570211 |
| 53 | TGFBR2 | 0.78150852 |
| 54 | KDR | 0.75728906 |
| 55 | PIM1 | 0.75072552 |
| 56 | PKN1 | 0.74864548 |
| 57 | MAPK11 | 0.74282398 |
| 58 | MARK2 | 0.70774179 |
| 59 | IRAK2 | 0.66254409 |
| 60 | MAP3K1 | 0.65029309 |
| 61 | CDK19 | 0.64793834 |
| 62 | PIK3CG | 0.64374640 |
| 63 | EPHB1 | 0.63486830 |
| 64 | PRKD2 | 0.60522611 |
| 65 | CDC42BPA | 0.59100962 |
| 66 | RPS6KA4 | 0.56327380 |
| 67 | MAP3K5 | 0.55047623 |
| 68 | DYRK1B | 0.54660302 |
| 69 | LRRK2 | 0.53207082 |
| 70 | MAPK4 | 0.52721141 |
| 71 | MAPK13 | 0.51609487 |
| 72 | SIK1 | 0.49717571 |
| 73 | PRKD1 | 0.49461768 |
| 74 | CDK4 | 0.48650228 |
| 75 | MAPKAPK2 | 0.47713158 |
| 76 | FLT3 | 0.46201556 |
| 77 | HIPK2 | 0.45294383 |
| 78 | PASK | 0.42529725 |
| 79 | PDPK1 | 0.41939344 |
| 80 | MOS | 0.38749354 |
| 81 | IRAK1 | 0.38676121 |
| 82 | ADRBK2 | 0.38194513 |
| 83 | STK11 | 0.33449780 |
| 84 | CHUK | 0.33217992 |
| 85 | PRKCD | 0.31471058 |
| 86 | RPS6KA1 | 0.30645410 |
| 87 | MAPK7 | 0.30536898 |
| 88 | ABL1 | 0.29480709 |
| 89 | MAP3K7 | 0.29476213 |
| 90 | NLK | 0.28922083 |
| 91 | PRKCZ | 0.25988556 |
| 92 | MAP2K2 | 0.24060197 |
| 93 | NTRK3 | 0.22979997 |
| 94 | EGFR | 0.22655802 |
| 95 | INSR | 0.22324098 |
| 96 | ILK | 0.22135974 |
| 97 | GRK5 | 0.20816653 |
| 98 | CAMKK1 | 0.20487173 |
| 99 | DAPK1 | 0.20247746 |
| 100 | MAPK3 | 0.18941479 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 4.47539813 |
| 2 | Asthma_Homo sapiens_hsa05310 | 4.45208006 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 4.35304055 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.26644901 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.84091089 |
| 6 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.54376238 |
| 7 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.43918053 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 3.18961160 |
| 9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.17186887 |
| 10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.89050191 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.88891413 |
| 12 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.81505148 |
| 13 | Viral myocarditis_Homo sapiens_hsa05416 | 2.58275712 |
| 14 | Tuberculosis_Homo sapiens_hsa05152 | 1.95410661 |
| 15 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.89110299 |
| 16 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.89109193 |
| 17 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 1.88989863 |
| 18 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.75369899 |
| 19 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.62387765 |
| 20 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.60429407 |
| 21 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.58636980 |
| 22 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.57411562 |
| 23 | Influenza A_Homo sapiens_hsa05164 | 1.52912691 |
| 24 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.30196282 |
| 25 | Phagosome_Homo sapiens_hsa04145 | 1.29127629 |
| 26 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.27807212 |
| 27 | Measles_Homo sapiens_hsa05162 | 1.20104176 |
| 28 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.16936520 |
| 29 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.15896143 |
| 30 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.10511539 |
| 31 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.06555779 |
| 32 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.96347402 |
| 33 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.95700186 |
| 34 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.94223373 |
| 35 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.92604008 |
| 36 | Malaria_Homo sapiens_hsa05144 | 0.91810133 |
| 37 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.86481442 |
| 38 | Pertussis_Homo sapiens_hsa05133 | 0.79129697 |
| 39 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.76842726 |
| 40 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.76781742 |
| 41 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.72042479 |
| 42 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.71448570 |
| 43 | HTLV-I infection_Homo sapiens_hsa05166 | 0.70261636 |
| 44 | Hepatitis B_Homo sapiens_hsa05161 | 0.70085072 |
| 45 | Legionellosis_Homo sapiens_hsa05134 | 0.69812331 |
| 46 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.67981708 |
| 47 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.63554963 |
| 48 | Platelet activation_Homo sapiens_hsa04611 | 0.63546692 |
| 49 | Shigellosis_Homo sapiens_hsa05131 | 0.58103385 |
| 50 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.51794374 |
| 51 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.48080043 |
| 52 | Hepatitis C_Homo sapiens_hsa05160 | 0.47896345 |
| 53 | Apoptosis_Homo sapiens_hsa04210 | 0.45733277 |
| 54 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.43594680 |
| 55 | Salmonella infection_Homo sapiens_hsa05132 | 0.42561660 |
| 56 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.42552552 |
| 57 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.40266666 |
| 58 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.38691319 |
| 59 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.35308806 |
| 60 | Other glycan degradation_Homo sapiens_hsa00511 | 0.34151527 |
| 61 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.32512689 |
| 62 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.31936039 |
| 63 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.31873800 |
| 64 | Endocytosis_Homo sapiens_hsa04144 | 0.31419178 |
| 65 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.30824499 |
| 66 | Lysosome_Homo sapiens_hsa04142 | 0.30319859 |
| 67 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.26383710 |
| 68 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.25437856 |
| 69 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.25182478 |
| 70 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.22626595 |
| 71 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.22604359 |
| 72 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.18307531 |
| 73 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.17906100 |
| 74 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.17859145 |
| 75 | Colorectal cancer_Homo sapiens_hsa05210 | 0.15422236 |
| 76 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.13712940 |
| 77 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.13466515 |
| 78 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.13298364 |
| 79 | Morphine addiction_Homo sapiens_hsa05032 | 0.12297086 |
| 80 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.11370521 |
| 81 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.11190290 |
| 82 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.10610905 |
| 83 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.09178602 |
| 84 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.08851974 |
| 85 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.08661980 |
| 86 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.08493198 |
| 87 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.08073337 |
| 88 | Olfactory transduction_Homo sapiens_hsa04740 | 0.07617901 |
| 89 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.07523556 |
| 90 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.05463521 |
| 91 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.05432789 |
| 92 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.05240633 |
| 93 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.05143337 |
| 94 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.05033359 |
| 95 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.04886725 |
| 96 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.04878526 |
| 97 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.04459607 |
| 98 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.04190442 |
| 99 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.03778868 |
| 100 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.02245242 |

